Power Law company profile

Prexton therapeutics

Biotech & Life Sciences · Oss, Netherlands · Founded 2012 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$500M–1B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Investors

5 investors on Prexton therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage

Eclosion

Series A 2 investors entered at this stage

M Ventures

Ysios Capital

Series B+ 2 investors entered at this stage

Seroba Life Sciences

Forbion Capital Partners

Global footprint

Where Prexton therapeutics has talent and traffic

Web traffic by country

1.2K monthly visits
across markets

🇧🇷 Brazil33.3%

🇮🇳 India25%

🇨🇴 Colombia16.7%

🏳️ Taiwan8.3%

🇹🇷 Turkey8.3%

Top 5 markets shown

Patent intelligence

$26k patent portfolio · 2 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$26k

<0.01% of valuation · 11099.3× smaller than top peer SAGE Therapeutics ($289M)

2 active patent families

Where Prexton therapeutics innovates Glutamic acidChromoneNervous systemOral administrationMedicinal chemistry

Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Prexton therapeutics on the five Patsnap quality dimensions

Prexton therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Prexton therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Prexton therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Prexton therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo